As part of the One Voice Against Cancer (OVAC) coalition, ASTRO joined 32 other organizations in a statement opposing recent layoffs and funding cuts at the National Institutes of Health (NIH), National Cancer Institute (NCI), the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The statement pointed out several potentially negative impacts from recent executive actions. They include reduced economic activity and jobs in states reliant on research dollars and America losing its competitive edge in biomedical research. Other potential impacts include terminated clinical trials, closed medical labs and access to innovative cancer treatments. OVAC is a group of non-profit organizations led by the American Cancer Society Cancer Action Network delivering a unified message to Congress on the importance of increased appropriations for cancer-related activities.